Search

Author/Creator Gelber, Richard D.

11. Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2–positive early breast cancer: Analysis from the NeoALTTO (BIG 1‐06) and ALTTO (BIG 2‐06) trials. Issue 2 (18th October 2018)

Authors:
Lambertini, Matteo; Martel, Samuel; Campbell, Christine; Guillaume, Sébastien; Hilbers, Florentine S.; Schuehly, Uwe; Korde, Larissa; Azim, Hatem A.; Di Cosimo, Serena; Tenglin, Richard C.; Huober, Jens; Baselga, José; Moreno‐Aspitia, Alvaro; Piccart‐Gebhart, Martine; Gelber, Richard D.; de Azamb...
Journal:
Cancer
Issue:
Volume 125:Issue 2(2019)
Page Start:
307
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. Six-year absolute invasive disease-free survival benefit of adding adjuvant pertuzumab to trastuzumab and chemotherapy for patients with early HER2-positive breast cancer: A Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of the APHINITY (BIG 4-11) trial. (May 2022)

Authors:
Gelber, Richard D.; Wang, Xin V.; Cole, Bernard F.; Cameron, David; Cardoso, Fatima; Tjan-Heijnen, Vivianne; Krop, Ian; Loi, Sherene; Salgado, Roberto; Kiermaier, Astrid; Frank, Elizabeth; Fumagalli, Debora; Caballero, Carmela; de Azambuja, Evandro; Procter, Marion; Clark, Emma; Restuccia, Eleono...
Journal:
European journal of cancer
Issue:
Volume 166(2022)
Page Start:
219
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. Survival outcomes of the NeoALTTO study (BIG 1–06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer. (September 2019)

Authors:
Huober, Jens; Holmes, Eileen; Baselga, José; de Azambuja, Evandro; Untch, Michael; Fumagalli, Debora; Sarp, Severine; Lang, Istvan; Smith, Ian; Boyle, Frances; Xu, Binghe; Lecocq, Christophe; Wildiers, Hans; Jouannaud, Christelle; Hackman, John; Dasappa, Lokanatha; Ciruelos, Eva; Toral Pena, Juan...
Journal:
European journal of cancer
Issue:
Volume 118(2019)
Page Start:
169
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D). (May 2021)

Authors:
Moreno-Aspitia, Alvaro; Holmes, Eileen M.; Jackisch, Christian; de Azambuja, Evandro; Boyle, Frances; Hillman, David W.; Korde, Larissa; Fumagalli, Debora; Izquierdo, Miguel A.; McCullough, Ann E.; Wolff, Antonio C.; Pritchard, Kathleen I.; Untch, Michael; Guillaume, Sébastien; Ewer, Michael S.; ...
Journal:
European journal of cancer
Issue:
Volume 148(2021)
Page Start:
287
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy. (October 2021)

Authors:
Partridge, Ann H.; Niman, Samuel M.; Ruggeri, Monica; Peccatori, Fedro A.; Azim, Hatem A.; Colleoni, Marco; Saura, Cristina; Shimizu, Chikako; Sætersdal, Anna Barbro; Kroep, Judith R.; Mailliez, Audrey; Warner, Ellen; Borges, Virginia F.; Amant, Frédéric; Gombos, Andrea; Kataoka, Akemi; Rousset-J...
Journal:
Breast
Issue:
Volume 59(2021)
Page Start:
327
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗